MSI Methylation Sciences Inks $18.2M
MSI Methylation Sciences Inc., a Vancouver-based pharmaceuticals startup, has raised 13.5 million euro ($18.2 million) in Series A financing. Inventages led the round, which included existing backers Working Opportunity Fund, managed by GrowthWorks; BC Advantage Funds; and several unnamed angel investors.
30 September 2011•2 mins read
